Carl Zeiss Meditec AG (AFX) — Free Cash Flow Generation Index
Carl Zeiss Meditec AG (AFX) has a Free Cash Flow Generation Index of 0.47x as of September 2025. Free cash flow of €67.56 Million represents 0% of operating cash flow (€144.16 Million). Explore AFX capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Carl Zeiss Meditec AG Free Cash Flow Generation Index (2014–2025)
Historical FCF Generation Index trend for Carl Zeiss Meditec AG across 12 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Carl Zeiss Meditec AG.
Annual Free Cash Flow Generation for Carl Zeiss Meditec AG (2014–2025)
Year-by-year Free Cash Flow Generation Index for Carl Zeiss Meditec AG. Check Carl Zeiss Meditec AG total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.64x | €133.26 Million | €209.86 Million | €76.59 Million | ▲ +65.1% |
| 2024 | 0.38x | €95.11 Million | €247.32 Million | €152.20 Million | ▼ -29.6% |
| 2023 | 0.55x | €137.00 Million | €250.86 Million | €65.65 Million | ▼ -3.2% |
| 2022 | 0.56x | €106.23 Million | €188.20 Million | €42.80 Million | ▼ -31.0% |
| 2021 | 0.82x | €296.56 Million | €362.66 Million | €30.12 Million | ▲ +9.3% |
| 2020 | 0.75x | €133.54 Million | €178.53 Million | €29.32 Million | ▼ -5.0% |
| 2019 | 0.79x | €172.92 Million | €219.63 Million | €20.35 Million | ▼ -3.3% |
| 2018 | 0.81x | €152.45 Million | €187.21 Million | €16.54 Million | ▲ +2481.9% |
| 2017 | -0.03x | €-1.29 Million | €37.73 Million | €13.66 Million | ▼ -102.7% |
| 2016 | 1.25x | €139.69 Million | €111.77 Million | €27.92 Million | ▲ +6.6% |
| 2015 | 1.17x | €66.52 Million | €56.74 Million | €9.77 Million | ▼ -0.4% |
| 2014 | 1.18x | €74.25 Million | €63.10 Million | €11.14 Million | — |